Concepts (93)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Syringomyelia | 1 | 2023 | 9 | 0.880 |
Why?
|
| Arnold-Chiari Malformation | 1 | 2023 | 13 | 0.880 |
Why?
|
| Scoliosis | 1 | 2023 | 34 | 0.860 |
Why?
|
| Palatine Tonsil | 1 | 2023 | 10 | 0.220 |
Why?
|
| Central Nervous System | 1 | 2023 | 36 | 0.220 |
Why?
|
| Spine | 1 | 2023 | 59 | 0.210 |
Why?
|
| Cerebral Angiography | 4 | 2006 | 37 | 0.200 |
Why?
|
| Carotid-Cavernous Sinus Fistula | 1 | 2001 | 2 | 0.190 |
Why?
|
| Meningeal Arteries | 1 | 2001 | 3 | 0.190 |
Why?
|
| Stroke | 3 | 2015 | 233 | 0.190 |
Why?
|
| Catheterization, Peripheral | 1 | 2001 | 24 | 0.180 |
Why?
|
| Postoperative Hemorrhage | 1 | 2001 | 30 | 0.180 |
Why?
|
| Embolization, Therapeutic | 1 | 2001 | 45 | 0.180 |
Why?
|
| Pituitary Neoplasms | 1 | 2001 | 48 | 0.180 |
Why?
|
| Adenoma | 1 | 2001 | 59 | 0.180 |
Why?
|
| Infant, Newborn | 1 | 2023 | 841 | 0.170 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2006 | 464 | 0.160 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2001 | 309 | 0.160 |
Why?
|
| Meninges | 1 | 2017 | 1 | 0.150 |
Why?
|
| Meningitis | 1 | 2017 | 11 | 0.150 |
Why?
|
| Cranial Nerve Diseases | 1 | 2017 | 10 | 0.150 |
Why?
|
| Mycophenolic Acid | 1 | 2017 | 16 | 0.140 |
Why?
|
| Rituximab | 1 | 2017 | 59 | 0.140 |
Why?
|
| Child | 1 | 2023 | 2141 | 0.140 |
Why?
|
| Small Fiber Neuropathy | 1 | 2016 | 1 | 0.140 |
Why?
|
| Purkinje Cells | 1 | 2016 | 7 | 0.140 |
Why?
|
| Chorea | 1 | 2016 | 8 | 0.140 |
Why?
|
| Glucocorticoids | 1 | 2017 | 114 | 0.140 |
Why?
|
| Paraneoplastic Syndromes | 1 | 2016 | 8 | 0.140 |
Why?
|
| Small Cell Lung Carcinoma | 1 | 2016 | 11 | 0.140 |
Why?
|
| Postoperative Complications | 1 | 2001 | 604 | 0.130 |
Why?
|
| Cafe-au-Lait Spots | 1 | 2015 | 1 | 0.130 |
Why?
|
| Nerve Sheath Neoplasms | 1 | 2015 | 3 | 0.130 |
Why?
|
| Neurofibromatosis 1 | 1 | 2015 | 6 | 0.130 |
Why?
|
| Hypopituitarism | 1 | 2015 | 5 | 0.130 |
Why?
|
| Hormone Replacement Therapy | 1 | 2015 | 8 | 0.130 |
Why?
|
| Cerebral Veins | 1 | 1995 | 11 | 0.130 |
Why?
|
| Brain Diseases | 1 | 2015 | 35 | 0.130 |
Why?
|
| Immunoglobulin G | 1 | 2017 | 266 | 0.130 |
Why?
|
| Testosterone | 1 | 2015 | 70 | 0.130 |
Why?
|
| Nerve Tissue Proteins | 1 | 2016 | 150 | 0.130 |
Why?
|
| Autoantibodies | 1 | 2016 | 463 | 0.110 |
Why?
|
| Male | 4 | 2023 | 12854 | 0.110 |
Why?
|
| Lung Neoplasms | 1 | 2016 | 340 | 0.100 |
Why?
|
| Humans | 9 | 2023 | 26789 | 0.100 |
Why?
|
| Treatment Outcome | 5 | 2017 | 2260 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2017 | 801 | 0.070 |
Why?
|
| Cerebral Infarction | 1 | 2006 | 26 | 0.070 |
Why?
|
| Magnetic Resonance Angiography | 3 | 2006 | 27 | 0.060 |
Why?
|
| Angioplasty | 1 | 2004 | 12 | 0.060 |
Why?
|
| Middle Cerebral Artery | 1 | 2004 | 48 | 0.060 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2004 | 44 | 0.060 |
Why?
|
| Adult | 3 | 2015 | 7365 | 0.050 |
Why?
|
| Pituitary Gland | 1 | 2001 | 53 | 0.050 |
Why?
|
| Brain Ischemia | 1 | 2002 | 80 | 0.050 |
Why?
|
| Hypertrophy | 1 | 2017 | 37 | 0.040 |
Why?
|
| Remission Induction | 1 | 2017 | 50 | 0.040 |
Why?
|
| Immunologic Factors | 1 | 2017 | 47 | 0.030 |
Why?
|
| Hydrolases | 1 | 2016 | 11 | 0.030 |
Why?
|
| Biopsy | 1 | 2017 | 199 | 0.030 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2016 | 49 | 0.030 |
Why?
|
| Piracetam | 1 | 2015 | 1 | 0.030 |
Why?
|
| Fluid Therapy | 1 | 2015 | 14 | 0.030 |
Why?
|
| Hemangioma | 1 | 1995 | 8 | 0.030 |
Why?
|
| Anticonvulsants | 1 | 2015 | 19 | 0.030 |
Why?
|
| Functional Neuroimaging | 1 | 2015 | 23 | 0.030 |
Why?
|
| Seizures | 1 | 2015 | 46 | 0.030 |
Why?
|
| Diarrhea | 1 | 2015 | 53 | 0.030 |
Why?
|
| Middle Aged | 2 | 2017 | 6803 | 0.030 |
Why?
|
| Thrombolytic Therapy | 2 | 2006 | 36 | 0.030 |
Why?
|
| Disease Progression | 1 | 2017 | 450 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2016 | 367 | 0.030 |
Why?
|
| Antiviral Agents | 1 | 2015 | 104 | 0.030 |
Why?
|
| Female | 3 | 2004 | 14434 | 0.030 |
Why?
|
| Brain Neoplasms | 1 | 1995 | 288 | 0.030 |
Why?
|
| Brain | 1 | 2017 | 698 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2015 | 496 | 0.020 |
Why?
|
| Infusions, Intra-Arterial | 1 | 2006 | 5 | 0.020 |
Why?
|
| Neurologic Examination | 1 | 2006 | 21 | 0.020 |
Why?
|
| Observer Variation | 1 | 2006 | 43 | 0.020 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2006 | 36 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 2006 | 99 | 0.020 |
Why?
|
| Heparin | 1 | 2006 | 110 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2006 | 508 | 0.020 |
Why?
|
| Retreatment | 1 | 2004 | 12 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2004 | 68 | 0.010 |
Why?
|
| Anticoagulants | 1 | 2006 | 293 | 0.010 |
Why?
|
| Prognosis | 1 | 2006 | 759 | 0.010 |
Why?
|
| Angiography, Digital Subtraction | 1 | 2002 | 18 | 0.010 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2002 | 16 | 0.010 |
Why?
|
| Acute Disease | 1 | 2002 | 153 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2004 | 1924 | 0.010 |
Why?
|
| Aged | 1 | 2004 | 5155 | 0.010 |
Why?
|